Treatment of multifocal Bowen's disease in immunocompromised women with surgery and topical imiquimod

Obstet Gynecol. 2012 Feb;119(2 Pt 2):442-444. doi: 10.1097/AOG.0b013e318236f1a0.

Abstract

Background: In human immunodeficiency virus (HIV)-infected women, Bowen's disease may be difficult to treat successfully with surgery alone. Imiquimod cream, effective in treating Bowen's disease in healthy women, may be a useful postsurgical treatment in immunocompromised women.

Cases: Two HIV-infected women had both Bowen's disease and severe cervical dysplasia. In both cases, Bowen's disease, but not cervical dysplasia, recurred after surgical treatment. When treated with topical 5% imiquimod cream twice weekly for 4 months, 70-80% reduction in lesions were observed in both patients. Follow-up biopsies of remaining lesions were vulvar intraepithelial neoplasia 1.

Conclusion: Imiquimod cream, in combination with surgical treatment, may be an appropriate strategy for treatment of Bowen's disease in HIV-infected and other immunocompromised women.

Publication types

  • Case Reports
  • Research Support, N.I.H., Intramural

MeSH terms

  • Adult
  • Aminoquinolines / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Bowen's Disease / complications
  • Bowen's Disease / drug therapy*
  • Bowen's Disease / surgery
  • Female
  • HIV Infections / complications
  • HIV Infections / drug therapy
  • Humans
  • Imiquimod
  • Immunocompromised Host
  • Skin Neoplasms / complications
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / surgery
  • Uterine Cervical Dysplasia / complications
  • Uterine Cervical Dysplasia / surgery
  • Uterine Cervical Neoplasms / complications
  • Uterine Cervical Neoplasms / surgery
  • Vulvar Neoplasms / complications
  • Vulvar Neoplasms / drug therapy*
  • Vulvar Neoplasms / surgery

Substances

  • Aminoquinolines
  • Antineoplastic Agents
  • Imiquimod